EXPLORE BY CATEGORY
September 9, 2014
BY KAREN CROWLEY How long should myeloma patients continue a treatment, such as Revlimid or Velcade? A leading myeloma expert says that continuing therapy as long as possible is beneficial for most patients. Myeloma Crowd founder Jenny Ahlstrom interviewed Dr. Antonio Palumbo, MD about continuous maintenance therapy for the mPatient Myeloma Radio podcast Aug. 25. Dr. Palumbo is chief of the Myeloma Unit of the Department of Oncology, Section of Hematology at the University of T[...]
August 22, 2014
Monday, August 25, 7 am PDT, 8 am MDT, 9 am CDT, 10 am EDT Call in by phone to listen live: 347-637-2631 or Listen Live Via Computer Do all myeloma patients need continuous maintenance therapy regardless of maintenance status? Dr. Antonio Palumbo presented a recent paper at ASCO 2014 showing it may be important and even necessary. Learn more from this renown international myeloma researcher about when continuous maintenance may be needed, who should be receiving it and which therapies sho[...]
Get Started Today.
Find a Clinical Trial that's Right for You
Thanks to our site sponsors: